Bayer shareholders vent ire over Monsanto-linked stock rout



Bayer shareholders vented their anger over its stock price slump on Friday as litigation risks mount from the German drugmaker’s $63 billion takeover of seed maker Monsanto. David Pollard reports.





READ SOURCE

See also  TN to launch trial to study efficacy of BCG vaccine to reduce COVID-19 mortality for elders

LEAVE A REPLY

Please enter your comment!
Please enter your name here